Among 716 samples across 29 cancer types, we interestingly observe that most of the negative regulators, such as PER1, PER2, PER3, CRY1, CRY2, and NR1D2, are down-regulated in a wide range of cancers (Figures 1A,B). This evidence concerns the gene NR1D2 and cancer.